Target intelligence / Profile preview

Oxidative stress signaling mediators

Molecular classification
Enzyme, Transcription factor, Other
01

Overview

Oxidative stress signaling mediators represent a broad class of molecules, including reactive oxygen species (ROS), antioxidant enzymes, and redox-sensitive transcription factors, that collectively maintain cellular redox homeostasis. Key components such as the Nrf2-Keap1 pathway and NF-kappaB serve as sensors that detect oxidative imbalances and initiate gene expression programs to mitigate damage (Sies & Jones, 2020, Nature Reviews Molecular Cell Biology). In pathological states like cancer, neurodegeneration, and cardiovascular disease, these mediators often become dysregulated, leading to chronic oxidative stress and tissue injury (Forman & Zhang, 2021, Nature Reviews Drug Discovery). Pharmacological strategies targeting these mediators include the use of direct antioxidants to scavenge ROS or Nrf2 activators to bolster endogenous defense mechanisms (Hayes & Dinkova-Kostova, 2014, Trends in Biochemical Sciences). However, the dual role of ROS as both damaging agents and essential signaling molecules for cell growth and immunity creates a therapeutic challenge known as the antioxidant paradox (Halliwell, 2011, Free Radical Research). Consequently, drug development in this area requires precise modulation to avoid disrupting necessary physiological signaling while effectively reducing pathological oxidative stress.

Other names
Redox signaling moleculesOxidative stress pathway componentsReactive oxygen species signaling mediatorsAntioxidant response elements signaling components
02

Mechanism of action

Activation of antioxidant response elements (ARE) via Nrf2, inhibition of NF-kappaB signaling, and direct scavenging of reactive oxygen species.

03

Biological functions

Signal transductionApoptosisImmune responseCell deathOther
04

Disease associations

CancerInflammationNeurodegenerative diseaseCardiovascular diseaseOther
05

Safety considerations

Interference with physiological ROS signalingPotential for promoting tumor survival in certain contextsAntioxidant paradox
06

Interacting drugs

N-acetylcysteine

4 more in the full profile.

07

Biomarkers

Malondialdehyde (MDA)8-hydroxy-2'-deoxyguanosine (8-OHdG)Glutathione (GSH) levelsSuperoxide dismutase (SOD) activity

Beyond the preview

Go deeper on Oxidative stress signaling mediators.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Oxidative stress signaling mediators.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call